| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.2B | $3.8B | $3.9B | $4.2B | $4.1B | $4.0B | $4.0B | $4.0B |
| Cost of Revenue | $0.1B | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.1B | $1.3B | $1.4B | $1.4B | $1.3B | $1.4B | $1.4B | $1.4B |
| Operating Income | $-0.1B | $-0.0B | $0.1B | $0.1B | $0.2B | $0.2B | $0.1B | $0.2B |
| Net Income | $0.0B | $-0.0B | $0.1B | $0.0B | $0.2B | $0.2B | $0.1B | $0.1B |
| EPS (Basic) | $0.57 | $-0.46 | $0.64 | $0.35 | $1.80 | $2.66 | $1.47 | $1.75 |
| EPS (Diluted) | $0.56 | $-0.46 | $0.63 | $0.35 | $1.77 | $2.62 | $1.44 | $1.72 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.7B | $10.4B | $10.8B | $11.1B | $10.3B | $9.7B | $8.2B | $7.3B |
| Current Assets | $0.1B | $1.3B | $1.4B | $1.7B | $1.6B | $2.6B | $1.6B | $1.8B |
| Cash & Equivalents | $0.1B | $0.1B | $0.1B | $0.3B | $0.2B | $1.3B | $0.3B | $0.6B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $0.2B | $0.9B | $0.9B | $1.2B | $0.9B | $0.9B | $0.8B | $0.7B |
| Stockholders' Equity | $2.6B | $4.6B | $4.6B | $4.6B | $4.5B | $4.4B | $4.2B | $4.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.2B | $0.9B | $0.9B | $0.8B | $0.8B | $1.2B | $0.7B | $0.7B |
| Investing Cash Flow | $2.4B | $-0.6B | $-0.7B | $-1.2B | $-2.0B | $-1.2B | $-0.9B | $-0.5B |
| Capital Expenditures | $0.0B | $0.5B | $0.6B | $0.6B | — | — | — | — |
| Financing Cash Flow | $-2.7B | $-0.3B | $-0.3B | $0.5B | $0.1B | $0.9B | $-0.2B | $-0.0B |